The efficacy of subcutaneous implantable cardioverter defibrillator for primary prevention of sudden cardiac death in patients with chronic kidney disease.
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0005596
- Lead Sponsor
- Keimyung University Dongsan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 77
? Adult patients aged 19 or older
? Chronic kidney disease 3-5 stage patients
? Patients with left ventricular congestion rate of 35% or less
?a patient who has now been inserted with a subcutaneous defibrillator for primary prevention of sudden death, as recommended by medical guideline
? Those who are vulnerable to clinical research (as defined by KGCP)
? Ineligible for subcutaneous defibrillator screening
?Patients resuscitated after experiencing cardiac arrest
? Patients with a history of ventricular tachycardia
? Patients with artificial cardiac pacemakers and parenteral defibrillators
? Patients with a life expectancy of less than one year
? Patients scheduled for kidney transplantation
(viii) Patients who refuse to participate in clinical research
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method appropriate ventricular arrhythmia treatment frequency for subcutaneous insertion defibrillators
- Secondary Outcome Measures
Name Time Method death from any cause;arrhythmic death;non arrhythmic death;incidence of inappropriate shocks;implant related complications;all kinds of hospitalization